UP!
| Period | Date | Adjusted Actuals EPS | GAAP EPS |
|---|---|---|---|
| Q3 2022 | 2022-11-14 | Future report Set alerts | |
| Q2 2022 | 2022-08-11 | 0.48 | 0.48 |
| Q1 2022 | 2022-05-16 | -0.06 | -0.06 |
| Q4 2021 | 2022-03-10 | -0.06 | -0.06 |
| Q3 2021 | 2021-11-15 | -0.07 | -0.07 |
| Q2 2021 | 2021-08-16 | -0.08 | -0.08 |
| Q1 2021 | 2021-05-17 | -0.08 | -0.08 |
| Q4 2020 | 2021-03-15 | -0.10 | -0.10 |
| Q3 2020 | 2020-11-05 | -0.10 | -0.10 |
| Q2 2020 | 2020-08-10 | -0.08 | -0.08 |
| 2016-06-10 | Reiterated Rating | Jefferies Group | Buy | |
| 2016-05-06 | Upgrade | Seaport Global Securities | Accumulate to Buy | |
| 2016-05-03 | Reiterated Rating | HC Wainwright | Buy | $9.00 to $7.00 |
| 2016-05-02 | Reiterated Rating | Cowen and Company | Hold | |
| 2016-04-14 | Initiated Coverage | Janney Montgomery Scott | Neutral | |
| 2016-03-14 | Reiterated Rating | Cowen and Company | Hold | |
| 2016-03-10 | Reiterated Rating | Jefferies Group | Buy | $7.00 |
| 2016-03-08 | Reiterated Rating | Roth Capital | Buy | |
| 2016-03-08 | Reiterated Rating | Cowen and Company | Market Perform | |
| 2016-02-26 | Reiterated Rating | Cowen and Company | Hold | |
| 2016-01-08 | Reiterated Rating | Cowen and Company | Hold | |
| 2015-10-30 | Initiated Coverage | Jefferies Group | Hold to Buy | $3.50 to $7.00 |
| 2015-10-30 | Lower Price Target | RBC Capital | $7.00 to $6.00 | |
| 2015-10-30 | Lower Price Target | Royal Bank Of Canada | $7.00 to $6.00 | |
| 2015-10-15 | Boost Price Target | HC Wainwright | Buy | $9.00 to $10.00 |
| 2015-10-11 | Reiterated Rating | Roth Capital | Buy | |
| 2015-10-08 | Reiterated Rating | Cowen and Company | Hold | |
| 2015-10-05 | Boost Price Target | Roth Capital | Buy | $8.50 to $10.50 |
| 2015-10-02 | Boost Price Target | HC Wainwright | $8.50 to $9.00 | |
| 2015-09-22 | Reiterated Rating | Roth Capital | Buy | $7.50 to $8.50 |
| 2015-09-15 | Reiterated Rating | HC Wainwright | Buy | $8.50 |
| 2015-09-09 | Initiated Coverage | Roth Capital | Buy | $7.50 |
| 2015-09-02 | Initiated Coverage | HC Wainwright | Buy | $8.50 |
| 2015-08-04 | Reiterated Rating | Cowen and Company | Hold | |
| 2015-07-25 | Reiterated Rating | Roth Capital | Buy | $7.50 |
| 2015-07-09 | Reiterated Rating | Roth Capital | Buy | $7.50 |
| 2015-05-06 | Reiterated Rating | Mizuho | Neutral | $5.50 to $3.00 |
| 2015-05-05 | Lower Price Target | RBC Capital | Outperform | $8.00 to $7.00 |
| 2015-04-27 | Initiated Coverage | Global Hunter Securities | Accumulate | $22.00 |
| 2015-04-27 | Initiated Coverage | Seaport Global Securities | Accumulate | $22.00 |
| 2015-03-10 | Lower Price Target | JMP Securities | Market Outperform | $12.00 to $8.00 |
| 2015-03-10 | Downgrade | Cowen and Company | Outperform to Market Perform | $14.00 |
| 2015-03-10 | Lower Price Target | RBC Capital | Outperform | $12.00 to $8.00 |
| 2015-03-10 | Downgrade | Jefferies Group | Buy to Hold | $12.00 to $6.00 |
| 2015-03-09 | Downgrade | Mizuho | Buy to Neutral | $14.00 to $5.59 |
| 2015-02-26 | Upgrade | Mizuho | Neutral to Buy | $6.00 to $14.00 |
| 2015-02-09 | Set Price Target | Canaccord Genuity | Hold | $8.00 |
| 2014-11-06 | Downgrade | Mizuho | Buy to Neutral | $15.00 to $6.00 |
| 2014-09-26 | Downgrade | ROTH Capital | Buy to Neutral | |
| 2014-09-26 | Downgrade | Roth Capital | Buy to Neutral | $16.00 to $6.00 |
| 2014-08-12 | Lower Price Target | Jefferies Group | Buy | $17.00 to $16.00 |
| 2014-07-29 | Reiterated Rating | Cowen and Company | Outperform | $15.00 to $14.00 |
| 2014-07-29 | Downgrade | Piper Jaffray | Overweight to Neutral | $14.00 to $8.00 |
| 2014-07-29 | Downgrade | Piper Jaffray Cos. | Overweight to Neutral | $14.00 to $8.00 |
| 2014-07-28 | Lower Price Target | Mizuho | Buy | $20.00 to $15.00 |
| 2014-07-28 | Lower Price Target | JMP Securities | Outperform | $14.00 to $12.00 |
| 2014-07-28 | Lower Price Target | RBC Capital | Outperform | $15.00 to $12.00 |
| 2014-07-28 | Lower Price Target | Roth Capital | Buy | $16.00 |
| 2014-07-28 | Downgrade | Canaccord Genuity | Buy to Hold | $16.00 to $8.00 |
| 2014-06-17 | Initiated Coverage | JMP Securities | Outperform | $14.00 |
| 2014-04-17 | Initiated Coverage | Canaccord Genuity | Buy | $16.00 |
| 2014-04-14 | Initiated Coverage | Roth Capital | Buy | $22.00 |
| 2014-04-10 | Initiated Coverage | Jefferies Group | Buy | $17.00 |
| 2014-01-06 | Initiated Coverage | RBC Capital | Outperform | $15.00 |
| 2013-12-19 | Boost Price Target | Mizuho | Buy | $18.00 to $20.00 |
| 2013-12-17 | Reiterated | MLV & Co | Buy | $15 to $16.50 |
| 2013-12-17 | Boost Price Target | Jefferies Group | $14.00 to $15.00 | |
| 2013-12-17 | Boost Price Target | MLV & Co. | Buy | $15.00 to $16.50 |
| 2013-07-17 | Reiterated | Mizuho | Neutral | $13 to $18 |
| 2013-02-04 | Initiated | MLV & Co | Buy | $13 |
| 2012-10-10 | Resumed | Canaccord Genuity | Buy | $8 |
| 2011-05-26 | Initiated | Canaccord Genuity | Buy | $6 |
| 2016-06-10 | Reiterated Rating | Jefferies Group | Buy | |
| 2016-05-06 | Upgrade | Seaport Global Securities | Accumulate to Buy | |
| 2016-05-03 | Reiterated Rating | HC Wainwright | Buy | $9.00 to $7.00 |
| 2016-05-02 | Reiterated Rating | Cowen and Company | Hold | |
| 2016-04-14 | Initiated Coverage | Janney Montgomery Scott | Neutral |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In ACRX 42 funds of 2213 total. Show all
| Fund name | Ticker shares |
|---|---|
| Rock Springs Capital Management LP | 6.33M |
| Vanguard Group, Inc | 4.57M |
| BlackRock Inc. | 1.95M |
| GEODE CAPITAL MANAGEMENT, LLC | 1.16M |
| BlackRock Fund Advisors | 1.11M |
| BlackRock Institutional Trust Company, N.A. | 0.92M |
| STATE STREET CORP | 0.44M |
| TANG CAPITAL MANAGEMENT LLC | 0.39M |
| BRIDGEWAY CAPITAL MANAGEMENT INC | 0.25M |
| NORTHERN TRUST CORP | 0.22M |
| BlackRock Investment Management, LLC | 0.13M |
| SCHWAB CHARLES INVESTMENT MANAGEMENT INC | 0.13M |
| KCG Holdings, Inc. | 0.12M |
| CITADEL ADVISORS LLC | 0.11M |
| MORGAN STANLEY | 93841 |
| Name Relationship | Total Shares | Holding stocks |
|---|---|---|
| PERCEPTIVE ADVISORS LLC | 10.45% (4533728) | ACRX / AEGR / ALDX / BIOD / FOLD / LJPC / PLCC / RPRX / VSAR / ZGNX / |
| Three Arch Management IV, L.L.C. | 8.64% (3749918) | ACRX / CNCE / |
| THREE ARCH MANAGEMENT III LLC | 8.39% (3637169) | ACRX / CNCE / |
| Skyline Venture Partners Qualified Purchaser Fund IV L P | 6.62% (2871933) | ABIO / ACRX / CNCE / TTPH / |
| HOFFMAN STEPHEN J | 6.62% (2871933) | ACRX / DRNA / GNCA / |
| NOHRA GUY P | 5.78% (2507974) | ACRX / ZSPH / |
| Palmer Pamela P Chief Medical Officer | 0.96% (415801) | ACRX / |
| EDWARDS MARK G | 0.35% (150000) | ACRX / |
| KING RICHARD President and CEO | 0.31% (134567) | ACRX / ADMS / |
| WAN MARK A | 0.29% (126153) | ACRX / |
| ADAMS ADRIAN | 0.17% (75000) | ACRX / ARLZ / AUXL / POZN / |
| Dasu Badri N Chief Engineering Officer | 0.17% (74390) | ACRX / |
| Rosen Howard B | 0.12% (50000) | ACRX / |
| Hamel Lawrence G Chief Development Officer | 0.10% (41964) | ACRX / |
| SCHRECK THOMAS A | 0.04% (17982) | ACRX / |
| Angotti Vincent J. Chief Executive Officer | 0.03% (15000) | ACRX / |
| WELCH JAMES H Chief Financial Officer | 0.03% (15000) | ACRX / CLDN / |
| ASADORIAN RAFFI Chief Financial Officer | 0.02% (7000) | ACRX / AMRS / |
UM